CTRI/2016/01/006535已完成2 期
A Randomized, single blind, multi-center, parallel-arm, pilot scale study to ascertain the efficacy of coated Copper T in reducing bleeding side effects as Compared with Copper T 380 A for a maximum of 1 year
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 176
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age between 21 and 35 years (inclusive),
- •2. In good general health
- •3. With proven fertility and requesting
- •contraception(Nulliparous women requesting
- •contraception can also be included)
- •4. Has regular menstrual cycles (length of cycle
- •21-35 days) (i.e., endogenous Cyclicity without
- •hormonal contraceptive use)
排除标准
- •1.Known or suspected pregnancy
- •2.Breast feeding females
- •3.Patients using anti-coagulants
- •4.History of ectopic pregnancies
- •5.Any genital infection (until successfully treated)
- •6.Abnormal uterine bleeding of any origin including bleeding due to unknown causes
- •7.Abnormalities of the uterus resulting in distortion of the uterine cavity
- •8.Postpartum endometritis or infected abortion and MTP in the past < 3 months
- •9.Known or suspected uterine or cervical malignancy, including unresolved, abnormal â??Papâ?? smear
- •10.Untreated acute cervicitis until infection is controlled
- •11.Diagnosed Wilsonâ??s disease
- •12.Known allergy to copper
- •13.Conditions associated with increased susceptibility to infection. Such conditions include, but are not limited to leukemia, diabetes acquired immune deficiency syndrome (AIDS), and those requiring chronic corticosteroid therapies
- •14.Genital actinomycosis
- •15.A previously inserted IUD that has not been removed
研究者
相似试验
未知
2 期
Kagami/SDS ProjectGastrointestinal Endoscopic Tests (Including Endoscopic Polypectomy)JPRN-jRCT2080221299AstraZeneca
已完成
3 期
Ayurveda product clinical trial on overweight subjectsCTRI/2020/09/027807IndusViva HealthSciences Pvt Ltd70
招募中
2 期
A clinical trial to compare the effects of coded Unani research drugs UNIM 001+UNIM003 with Psoralen in the treatment of vitiligoCTRI/2013/12/004215Central Council for Research in Unani Medicine CCRUM New Delhi532
已完成
4 期
A post licensure clinical trial to evaluate the immunogenicity & safety of BE?s combined liquid pentavalent DTwP-rHepB-HIB vaccine (Combe Five) administered to healthy Indian infants in comparison with a licensed Pentavac SD? vaccine available in Indian marketCTRI/2011/04/001681Biological ELimited408
已完成
3 期
A phase III clinical trial to study the safety and immunogenicity of BEs combined pentavalent DTwP-rHepB-HIB liquid vaccine administered to 6-8 week old healthy Infants of either gender in comparison with a marketed vaccine.CTRI/2009/091/000456Biological E Limited Azamabad Hyderabad AP India90